I-123-Iododexetimide Preferentially Binds to the Muscarinic Receptor Subtype M-1 In Vivo

Geor Bakker, Wilhelmina A. Vingerhoets, Jan-Peter van Wieringen, Kora de Bruin, Jos Eersels, Jan de Jong, Youssef Chahid, Bart P. Rutten, Susan DuBois, Megan Watson, Adrian J. Mogg, Hongling Xiao, Michael Crabtree, David A. Collier, Christian C. Felder, Vanessa N. Barth, Lisa M. Broad, Oswald J. Bloemen, Thersee A. van Amelsvoort, Jan Booij

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)317-322
JournalJournal of Nuclear Medicine
Volume56
Issue number2
DOIs
Publication statusPublished - Feb 2015

Keywords

  • dexetimide
  • muscarinic receptors
  • cognition
  • SPECT imaging
  • characterization

Cite this

Bakker, G., Vingerhoets, W. A., van Wieringen, J-P., de Bruin, K., Eersels, J., de Jong, J., Chahid, Y., Rutten, B. P., DuBois, S., Watson, M., Mogg, A. J., Xiao, H., Crabtree, M., Collier, D. A., Felder, C. C., Barth, V. N., Broad, L. M., Bloemen, O. J., van Amelsvoort, T. A., & Booij, J. (2015). I-123-Iododexetimide Preferentially Binds to the Muscarinic Receptor Subtype M-1 In Vivo. Journal of Nuclear Medicine, 56(2), 317-322. https://doi.org/10.2967/jnumed.114.147488